Highlights Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
14.01 ^USD	+2.49%		+0.14%	+33.17%

04-15	Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-15	CI
Greenwich LifeSciences Secures Approval to Expand GLSI-100's Phase 3 Trial to Europe	02-22	MT
Greenwich Lifesciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators	02-22	CI
Greenwich LifeSciences, Inc. Provides Update on Phase III Clinical Trial, Flamingo-01	02-14	CI
Greenwich LifeSciences Shares Rise as Company Prepares FDA Filing for Breast Cancer Immunotherapy	02-14	DJ
Greenwich LifeSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-19	CI
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	23-08-25	DJ
Greenwich LifeSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Greenwich LifeSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Greenwich Lifesciences, Inc. Confirms the Interest in Both of Itsgp2 Phase Iib Clinical Trial and Phase Iii Clinical Trial, Flamingo-01	23-04-13	CI
Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023	22-12-01	BU
Greenwich LifeSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Greenwich LifeSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Greenwich LifeSciences Launches Late-Stage Breast Cancer Trial	22-08-11	MT
Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial	22-08-11	CI
Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial	22-08-03	CI
Greenwich LifeSciences, Inc. Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed	22-07-12	CI
Greenwich LifeSciences Suspends Share Repurchase Program	22-07-11	MT
Tranche Update on Greenwich LifeSciences, Inc.'s Equity Buyback Plan announced on January 24, 2022.	22-07-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Highlights

Filters